跳轉至內容
Merck

1.37156

SAFC

吡哆醇 盐酸盐

EMPROVE® EXPERT, Ph. Eur., BP, JP, USP, FCC

製藥生產

同義詞:

PN HCl, 吡哆醇 盐酸盐, 抗皮炎素 盐酸盐, 维生素 B6 盐酸盐

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C8H11NO3 · HCl
CAS號碼:
分子量::
205.64
Beilstein:
3632435
MDL號碼:
分類程式碼代碼:
41116107

agency

BP
JP
Ph. Eur.
USP

品質等級

法律遵循

FCC

產品線

EMPROVE® EXPERT

mp

214-215 °C (lit.)

應用

clinical nutrition
liquid formulation
parenterals
pharmaceutical
vitamins, nutraceuticals, and natural products

儲存溫度

15-25°C

SMILES 字串

Cl[H].Cc1ncc(CO)c(CO)c1O

InChI

1S/C8H11NO3.ClH/c1-5-8(12)7(4-11)6(3-10)2-9-5;/h2,10-12H,3-4H2,1H3;1H

InChI 密鑰

ZUFQODAHGAHPFQ-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

For protein-based therapeutics, such as monoclonal antibodies (mAbs) or plasma derived proteins, often highly concentrated protein formulations are required to meet intended dosing regimens. However, this usually comes with elevated viscosities and presents a challenge in the manufacturing process and final formulation. Our Viscosity Reduction Excipient Platform reduces the viscosity and helps overcome challenges associated with highly concentrated protein solutions.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation.
Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

The Viscosity Reduction Platform is based on the combination of two new excipients, one amino acid component with one anionic component, that together can better reduce protein viscosity beyond levels achieved with single excipients. Also, combining the two components enables a balance of viscosity reduction and protein stabilization. Pyridoxine hydrochloride Emprove® Expert is part of this new proprietary technology platform. Also, Pyridoxine hydrochloride (Vitamin B6) is used in clinical nutrition for treatment of vitamin B6 deficiency, anemia, mental retardation, Parkinson′s syndrome, gestational diabetes, tetanus and atherosclerosis.

包裝

1.37156.0100 / 100g / PE bottle
1.37156.1000 / 1kg / PE bottle
1.37156.9012 / 12kg / PE bucket

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

象形圖

Corrosion

訊號詞

Danger

危險聲明

危險分類

Eye Dam. 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

文章

This overview describes how use of viscosity-reducing excipients can address viscosity challenges in high concentration tangential flow filtration (TFF) and improve process economics.

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

與成人相比,兒童用藥面臨獨特的配方挑戰。在設計藥品時,請考慮兒童的發育生理和年齡特徵。品質問題會嚴重影響病患安全。因此,輔料品質、供應商選擇和供應鏈安全是至關重要的,特別是對於兒科配方。

相關內容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務